EJE: stimulating debate

A recent review published in European Journal of Endocrinology has prompted a response outlining the potential for use of etomidate in the management of hypercortisolaemia both within and outside of an intensive care setting. Read the letter to the Editor and the reply to the letter at the links below.

Therapy in endocrine disease: Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review by Veronica A Preda, Jonathan Sen, Niki Karavitaki and Ashley B Grossman (2012) European Journal of Endocrinology 167 137-143. DOI: 10.1530/EJE-12-0274

Letter to the Editor: Etomidate in the emergency management of hypercortisolaemia by Lip Min Soh, Kirun Gunganah, Scott A Akker, Philip Jones, Hasanin Khachi, Kumbirai Dodzo and William M Drake (2012) European Journal of Endocrinology 167 727-728. DOI: 10.1530/EJE-12-0698

Reply to letter: Practical aspects of etomidate use in the management of hypercortisolaemia by Veronica A Preda and Ashley B Grossman (2012) European Journal of Endocrinology 167 729. DOI: 10.1530/EJE-12-0746